Hespirion Report issue

For profit Phase 2
Founded: Allschwil Switzerland (1996)
Status: Acquired by Aptiv Solutions (2007) → now ICON (2014)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

Key: Hespirion (0) Acquired (1)

gastrin 17 vaccine (Gastrimmune) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 1